1. Home
  2. YAAS vs TOVX Comparison

YAAS vs TOVX Comparison

Compare YAAS & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

HOLD

Current Price

$0.75

Market Cap

6.7M

Sector

Technology

ML Signal

HOLD

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.17

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YAAS
TOVX
Founded
2018
2001
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.4M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
YAAS
TOVX
Price
$0.75
$0.17
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
43.8K
5.8M
Earning Date
01-01-0001
06-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.16
52 Week High
$7.00
$1.50

Technical Indicators

Market Signals
Indicator
YAAS
TOVX
Relative Strength Index (RSI) 14.58 41.68
Support Level $0.37 $0.17
Resistance Level $1.88 $0.26
Average True Range (ATR) 0.10 0.01
MACD -0.04 -0.00
Stochastic Oscillator 2.76 3.91

Price Performance

Historical Comparison
YAAS
TOVX

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: